Search
AN2 Therapeutics Inc
ANTXAdd to Watchlist
4.420USD
-0.280-5.96%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
159.19MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
1
analysts
Strong Buy
Current Rating
9.000
Target Price
+78.93%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
562
Total
5
Median
6
Average
Company name
Ratings
Analysts
AN2 Therapeutics Inc
ANTX
1
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
CRISPR Therapeutics AG
CRSP
26
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
1
2
3
...
113
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is AN2 Therapeutics Inc's price target?
Analysts forecast that AN2 Therapeutics Inc's price target is USD 1.50, with the highest forecast at USD 2.00 and the lowest forecast at USD 1.00.
How have AN2 Therapeutics IncANTX's recent earnings per share performed?
The market expectation was USD -0.29, while AN2 Therapeutics IncANTX's earnings per share (EPS) for the previous quarter was USD -0.29. EPS for the next quarter is expected at USD -0.23.
What is the analyst rating for AN2 Therapeutics Inc?
Based on the ratings of AN2 Therapeutics Inc's stock from 1 analysts, most analysts support a STRONG BUY trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as STRONG BUY. Please note that this is not trading advice. You still need to conduct your own analysis.